Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide

OBJECTIVES: Renal fibrosis accompanies all chronic kidney disorders, ultimately leading to end‐stage kidney disease and the need for dialysis or even renal replacement. As such, renal fibrosis poses a major threat to global health and the search for effective therapeutic strategies to prevent or tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Poosti, Fariba, Soebadi, Mohammad Ayodhia, Crijns, Helena, De Zutter, Alexandra, Metzemaekers, Mieke, Berghmans, Nele, Vanheule, Vincent, Albersen, Maarten, Opdenakker, Ghislain, Van Damme, Jo, Sprangers, Ben, Proost, Paul, Struyf, Sofie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810938/
https://www.ncbi.nlm.nih.gov/pubmed/35140938
http://dx.doi.org/10.1002/cti2.1370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810938/
https://www.ncbi.nlm.nih.gov/pubmed/35140938
http://dx.doi.org/10.1002/cti2.1370

Ejemplares similares